Undiagnosed morbidity in adult women with Turner's syndrome

Clinical Endocrinology
A S GardenW D Fraser

Abstract

Adult patients with Turner's syndrome are rarely followed up at specialist clinics after discharge from paediatric care but do have a predisposition to several long-term medical problems. We have assessed the undiagnosed morbidity that exists among adult women with Turner's syndrome. A group of 32 women (age range 17-52 years; mean 25 years) attending a specialist out-patient clinic. Blood samples were obtained at the initial visit for lipid assessment, thyroid function, gonadal status and routine biochemical profile. Bone mineral density (BMD) was measured in 31 of the women. Thirty-one women were receiving some form of oestrogen replacement. Two were receiving T4 therapy. In 50%, total cholesterol was greater than 5.2 mmol/l (range 3.4-9.3 mmol/l, mean 5.8 mmol/l) and 28% had an abnormality of thyroid function tests. Two women were newly diagnosed as hypothyroid, 6 had compensated hypothyroidism and one was under-replaced with T4. Lumbar spine BMD was below 100% of age matched reference range in 84% and below 75% in 26% of patients. Femoral neck BMD was below 100% of age matched reference range in 90% and below 75% in 10% of patients. There is a high incidence of undiagnosed lipid, thyroid and bone mineral density abnormaliti...Continue Reading

Citations

Apr 17, 2008·Reviews in Endocrine & Metabolic Disorders·Vladimir K Bakalov, Carolyn A Bondy
Dec 8, 2011·Endocrine·Christian TrolleClaus H Gravholt
Jan 7, 1999·Clinical Endocrinology·M Elsheikh, G S Conway
Feb 24, 2001·Clinical Endocrinology·H GuttmannZ Hochberg
May 29, 2002·Clinical Endocrinology·N Norman ChanGerard S Conway
Jul 5, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·M MoldavskyT Lerman-Sagie
Aug 13, 2009·Endocrine Journal·Izumi FukudaKazue Takano
Dec 1, 2008·Journal of Clinical Research in Pediatric Endocrinology·Özgür PirgonRıdvan Güçlü
Aug 11, 2001·Lancet·M B Ranke, P Saenger
Jun 17, 2003·Clinical Endocrinology·Claus Højbjerg GravholtJens Sandahl Christiansen
Apr 6, 2006·Clinical Endocrinology·Nehama Zuckerman-LevinZe'ev Hochberg
Jun 18, 2002·Best Practice & Research. Clinical Endocrinology & Metabolism·Gerard S Conway
Apr 1, 2012·Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology·Hitoshi KohnoToshiaki Tanaka
Jan 10, 2002·European Journal of Human Genetics : EJHG·M KveiborgM Kassem
Oct 1, 2019·The Journal of the American Academy of Orthopaedic Surgeons·Anna M AcostaKlane K White
Jul 15, 2011·The Journal of Clinical Endocrinology and Metabolism·Kim FreriksHenri J L M Timmers
Feb 15, 2002·Endocrine Reviews·M ElsheikhJ A H Wass
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Claus Højbjerg GravholtJens Sandahl Christiansen
Jul 15, 2017·European Journal of Endocrinology·Claus H GravholtUNKNOWN International Turner Syndrome Consensus Group
Jun 1, 2020·Current Pharmaceutical Design·Eirini KostopoulouDimitrios G Goulis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.